Agency Information Collection Activities; Proposed Collection; Comments Requested: Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine, 9429-9430 [2013-02877]

Download as PDF Federal Register / Vol. 78, No. 27 / Friday, February 8, 2013 / Notices use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. sroberts on DSK5SPTVN1PROD with NOTICES Overview of This Information Collection 1117–0006 17:23 Feb 07, 2013 Jkt 229001 [FR Doc. 2013–02876 Filed 2–7–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 189). (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form Number: DEA Form 189, Office of Diversion Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other forprofit. Other: None. Abstract: 21 U.S.C. 826 and 21 CFR 1303.22 and 1315.22 require that any person who is registered to manufacture any basic class of controlled substances listed in Schedule I or II and who desires to manufacture a quantity of such class, or who desires to manufacture using the List I chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, must apply on DEA Form 189 for a manufacturing quota for such quantity of such class or List I chemical. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that each form takes 0.5 hours (30 minutes) to complete. In total, 33 firms submit 641 responses, with each response taking 0.5 hours (30 minutes) to complete. This results in a total public burden of 320.5 hours annually. (6) An estimate of the total public burden (in hours) associated with the collection: In total, 33 firms submit 641 responses, with each response taking 0.5 hours (30 minutes) to complete. This results in a total public burden of 320.5 hours annually. If additional information is required contact: Jerri Murray, Department Clearance Officer, Policy and Planning Staff, Justice Management Division, Department of Justice, Two Constitution Square, 145 N Street, NE., Room 3W– 1407B, Washington, DC 20530. VerDate Mar<15>2010 Dated: February 5, 2013. Jerri Murray, Department Clearance Officer, PRA, United States Department of Justice. Drug Enforcement Administration [OMB Number 1117–0008] Agency Information Collection Activities; Proposed Collection; Comments Requested: Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine ACTION: 30-day notice. The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 77, Number 233, page 71832 on December 4, 2012, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until March 11, 2013. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–7285. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agencies estimate of the burden of the PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 9429 proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection 1117–0008 (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 250). (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Form 250, Office of Diversion Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: None. Abstract: 21 U.S.C. 826 and 21 CFR 1303.12 and 1315.32 require that U.S. companies who desire to use any basic class of controlled substances listed in Schedule I or II or the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for purposes of manufacturing during the next calendar year shall apply on DEA Form 250 for procurement quota for such class or List I chemical. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that each form takes 1⁄2 hour to complete. DEA estimates that 419 individual respondents will respond to this form. DEA estimates that 2,716 responses are received annually. (6) An estimate of the total public burden (in hours) associated with the collection: The total public burden for this collection is 1,358 hours annually. If additional information is required contact: Jerri Murray, Department Clearance Officer, Policy and Planning Staff, Justice Management Division, Department of Justice, Two Constitution Square, 145 N Street NE., Room 3W– 1407B, Washington, DC 20530. E:\FR\FM\08FEN1.SGM 08FEN1 9430 Federal Register / Vol. 78, No. 27 / Friday, February 8, 2013 / Notices Dated: February 5, 2013. Jerri Murray, Department Clearance Officer, PRA, United States Department of Justice. [FR Doc. 2013–02877 Filed 2–7–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0033] Agency Information Collection Activities; Proposed Collection; Comments Requested: Report of Mail Order Transaction sroberts on DSK5SPTVN1PROD with NOTICES ACTION: 30-day notice. The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 77, Number 236, page 73052, on December 7, 2012, allowing for a 60-day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until March 11, 2013. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/ or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–7285. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; VerDate Mar<15>2010 17:23 Feb 07, 2013 Jkt 229001 • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of Information Collection 1117–0033 (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Report of Mail Order Transaction. (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form Number: none; Office of Diversion Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: Not-for-Profit Institutions; State, Local or Tribal Government. Abstract: The Comprehensive Methamphetamine Control Act of 1996 (Pub. L. 104–237) (MCA) amended the Controlled Substances Act to require that each regulated person who engages in a transaction with a non-regulated person which involves ephedrine, pseudoephedrine, or phenylpropanolamine (including drug products containing these chemicals) and uses or attempts to use the Postal Service or any private or commercial carrier shall, on a monthly basis, submit a report of each such transaction conducted during the previous month to the Attorney General. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that there are 11 total respondents for this information collection; three (3) for paper form at 1 hour for each response; and eight (8) via electronic mail at 15 minutes per form, all of which report monthly. The total annual burden is 60 hours (36 hours for paper forms and 24 hours for electronic forms). (6) An estimate of the total public burden (in hours) associated with the collection: It is estimated that there are 60 annual burden hours associated with this collection. If additional information is required contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Room 3W– 1407B, Washington, DC 20530. Dated: February 5, 2013. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2013–02875 Filed 2–7–13; 8:45 am] BILLING CODE 4410–09–P LEGAL SERVICES CORPORATION Sunshine Act Meeting Notice The Legal Services Corporation’s Institutional Advancement Committee will meet telephonically on February 13, 2013. The meeting will commence at 4:00 p.m., Eastern Standard Time (EST), and will continue until the conclusion of the Committee’s agenda. LOCATION: F. William McCalpin Conference Center, Legal Services Corporation Headquarters, 3333 K Street NW., Washington, DC 20007. STATUS OF MEETING: Closed. Upon a vote of the Board of Directors, the meeting may be closed to the public to receive a presentation on and to discuss prospective funders for LSC’s development activities and 40th anniversary celebration. A verbatim written transcript will be made of the closed session of the Board and Institutional Advancement Committee meetings. The transcript of any portions of the closed session falling within the relevant provisions of the Government in the Sunshine Act, 5 U.S.C. § 552b(c)(9) will not be available for public inspection. A copy of the General Counsel’s Certification that, in his opinion, the closing is authorized by law will be available upon request. DATE AND TIME: Matters To Be Considered 1. Presentation on and discussion of prospective funders for LSC’s development activities and 40th anniversary celebration 2. Consider and act on adjournment of meeting CONTACT PERSON FOR INFORMATION: Katherine Ward, Executive Assistant to the Vice President & General Counsel, at (202) 295–1628. Questions may be sent by electronic mail to FR_NOTICE_QUESTIONS@lsc.gov. ACCESSIBILITY: LSC complies with the Americans with Disabilities Act and Section 504 of the 1973 Rehabilitation Act. Upon request, meeting notices and materials will be made available in alternative formats to accommodate individuals with disabilities. E:\FR\FM\08FEN1.SGM 08FEN1

Agencies

[Federal Register Volume 78, Number 27 (Friday, February 8, 2013)]
[Notices]
[Pages 9429-9430]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-02877]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0008]


Agency Information Collection Activities; Proposed Collection; 
Comments Requested: Application for Procurement Quota for Controlled 
Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine

ACTION: 30-day notice.

-----------------------------------------------------------------------

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA) will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. This proposed information collection was 
previously published in the Federal Register Volume 77, Number 233, 
page 71832 on December 4, 2012, allowing for a 60 day comment period.
    The purpose of this notice is to allow for an additional 30 days 
for public comment until March 11, 2013. This process is conducted in 
accordance with 5 CFR 1320.10.
    Written comments and/or suggestions regarding the items contained 
in this notice, especially the estimated public burden and associated 
response time, should be directed to the Office of Management and 
Budget, Office of Information and Regulatory Affairs, Attention 
Department of Justice Desk Officer, Washington, DC 20503. Additionally, 
comments may be submitted to OMB via facsimile to (202) 395-7285.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:
     Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
     Evaluate the accuracy of the agencies estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used;
     Enhance the quality, utility, and clarity of the 
information to be collected; and
     Minimize the burden of the collection of information on 
those who are to respond, including through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses.

Overview of This Information Collection 1117-0008

    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: Application for Procurement Quota 
for Controlled Substances and Ephedrine, Pseudoephedrine, and 
Phenylpropanolamine (DEA Form 250).
    (3) Agency form number, if any, and the applicable component of the 
Department sponsoring the collection: DEA Form 250, Office of Diversion 
Control, Drug Enforcement Administration, Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Business or other for-profit.
    Other: None.
    Abstract: 21 U.S.C. 826 and 21 CFR 1303.12 and 1315.32 require that 
U.S. companies who desire to use any basic class of controlled 
substances listed in Schedule I or II or the List I chemicals 
ephedrine, pseudoephedrine, and phenylpropanolamine for purposes of 
manufacturing during the next calendar year shall apply on DEA Form 250 
for procurement quota for such class or List I chemical.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: DEA estimates 
that each form takes \1/2\ hour to complete. DEA estimates that 419 
individual respondents will respond to this form. DEA estimates that 
2,716 responses are received annually.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: The total public burden for this collection is 
1,358 hours annually.
    If additional information is required contact: Jerri Murray, 
Department Clearance Officer, Policy and Planning Staff, Justice 
Management Division, Department of Justice, Two Constitution Square, 
145 N Street NE., Room 3W-1407B, Washington, DC 20530.


[[Page 9430]]


     Dated: February 5, 2013.
Jerri Murray,
Department Clearance Officer, PRA, United States Department of Justice.
[FR Doc. 2013-02877 Filed 2-7-13; 8:45 am]
BILLING CODE 4410-09-P